Status:
UNKNOWN
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Open-angle Glaucoma
Visual Field
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Open-angle glaucoma is a degeneration of the optic nerve, highlighted by campimetric alterations, and wose only current therapeutic target is the lowering of the intra-ocular pressure (using eye drops...
Eligibility Criteria
Inclusion
- diagnosis of GCAO defined by OCT RNFL alterations and visual fields defects
- age between 20 and 80 years old
- Well controled intra-ocular pressure under treatment (PIO\<21mmHg or decreased by 20% compared to initial the PIO)
Exclusion
- retinal or macular disease
- diagnosis of cataract or surgery of cataract during the follow-up
- allergy to citicolin
- ocular hypertonia due to a secondary cause (like corticosteroids)
- history of anterior, intermediate or posterior uveitis
- general treatment affecting PIO (beta blockers, corticosteroids)
- pregnancy or breastfeeding
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04499157
Start Date
August 1 2020
End Date
August 1 2023
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480